Garuda Therapeutics Appoints Giorgia Scapin, Ph.D., As Chief Scientific Officer | Citybiz
07/12/23, 6:00 PM
Location
cambridgeIndustry
biotechnology
science and engineering
health care
CAMBRIDGE, Mass.–– Garuda Therapeutics , a company creating off-the-shelf, durable blood stem cell-based cellular therapies, today announced the appointment of Giorgia Scapin, Ph.D., as Chief Scientific Officer. Transitioning from her previous role as Senior Vice President of Research and Development at Garuda, Dr. Scapin will oversee the company’s scientific strategy and lead the advancement of Garuda’s off-the-shelf hematopoietic stem cell therapies in her new role as Chief Scientific Officer.
Company Info
Location
215 first street
cambridge, massachusetts, united states
Additional Info
Garuda Therapeutics seeks to eliminate the need for stem cell donors for blood stem cell transplants. Garuda’s proprietary off-the-shelf hematopoietic stem cell (HSC) therapies enable self-renewing, HLA compatible and transgene-free HSCs, available immediately for patients. An immediately available, off-the-shelf option for patients could provide much needed strategies in a multitude of blood disorders across oncology, autoimmune indications, rare heme disorders and inborn errors of metabolism by effectively resetting bone marrow function.